THE US Food and Drug Administration (FDA) has taken steps to improve its product recall notification systems, drafting a new document that the body believes will provide consumers with more "actionable information."
Specifically, the draft guidance outlines when a company should issue a public recall warning, itemises what info should be included, and suggests when the FDA should take action to issue its own public warning.
To view the draft guidance document in full, CLICK HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 23 Jan 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Jan 18
